Electrospun nanofibers in drug delivery: Recent developments and perspectives

Therapeutic Delivery

Volumn 3, Issue 4, 2012, Pages 515-533

  Williams, Gareth R ^a   Chatterton, Nicholas P ^a   Nazir, Tahir ^a   Yu, Deng Guang ^b   Zhu, Li Min ^c   Branford White, Christopher J ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^c DONGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARMUSTINE; CHITOSAN; CONTRACEPTIVE AGENT; CYCLODEXTRIN DERIVATIVE; CYCLOSPORIN A; DICLOFENAC; DONEPEZIL; DOXORUBICIN; ELECTROSPUN NANOFIBER; EUDRAGIT; FERULIC ACID; HEPARIN; IBUPROFEN; KETOPROFEN; LIPOSOME; MACROGOL; METHYLPHENIDATE; NANOPARTICLE; NIFEDIPINE; OROS; PACLITAXEL; POLYCAPROLACTONE; POLYLACTIDE; POVIDONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ATTENTION DEFICIT DISORDER; CRYSTAL MODIFICATION; CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG TARGETING; ELECTROSPINNING; EMULSION; FLOW RATE; FREEZE DRYING; GLIOMA CELL; HEALTH CARE COST; HIGH THROUGHPUT SCREENING; HUMAN; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; METHODOLOGY; MICRONIZATION; MULTIPLE MYELOMA; NANOSIZING; NANOTECHNOLOGY; OVARY CANCER; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SALT FORMATION; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT; THERMODYNAMICS; VISCOSITY; WOUND HEALING;

EID: 84859264094     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.17     Document Type: Review

References (105)

1. Garcia-Bennett A, Nees M, Fadee B. In search of the holy grail: folate-targeted nanoparticles for cancer therapy. Biochem. Pharm. 81(8), 976-984 (2011).
2. Vemula PK, Boilard E, Syed A et al. On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease. J. Biomed. Mater. Res. 97(2), 103-110 (2011).
3. Forbes ZG, Yellen BB, Barbee KA, Friedman, G. An approach to targeted drug delivery based on uniform magnetic fields. IEEE Trans. Magn. 39(5), 3372-3377 (2003).
4. Wolraich ML, Greenhill LL, Pelham W et al. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 108(4), 883-892 (2001). (Pubitemid 32947657)
5. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issue and approaches for improvement. CNS Drugs 17(2), 117-131 (2003). (Pubitemid 36194310)
6. Keith S. Advances in psychotropic formulations. Progress Neuropsychopharmacol. Biol. Psychiatry 30(6), 996-1008 (2006). (Pubitemid 43949430)
7. Modi NB, Lindemulder B, Gupta SK. Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. J. Clin. Pharmacol. 40(4), 379-388 (2000).
8. Merisko-Liversidge EM and Liversidge G. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol. Pathol. 36(1), 43-48 (2008).
9. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50(1), 47-60 (2000). (Pubitemid 30326688)
10. Faller B. Improving solubility in lead optimization. Am. Pharm. Rev. 7, 30-33 (2004).
11. Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv. Drug Deliver. Rev. 59(7), 546-567 (2007). (Pubitemid 47285404)
12. Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharm. Toxicol. Methods 44(1), 235-249 (2000). (Pubitemid 32239479)
13. Ku MS, Dulin W. A biopharmaceutical classification-based right-first-time formulation approach to reduce human pharmacokinetic variability and project cycle time from first-in-human to clinical proof-of-concept. Pharm. Dev. Technol. 16(1), 1-18 (2010).
14. Thayer AM. Custom manufacturers take on drug solubility issues to help pharmaceutical firms move products through development. Chem. Eng. News 88, 13-18 (2011).
15. Yalkowsky SH, Valvani SC. Solubility and partitioning. I. Solubility of nonelectrolytes in water. J. Pharm. Sci. 69(8), 912-922 (1980).
16. Serajuddin ATM. Salt formation to improve drug solubility. Adv. Drug Deliv. Rev. 59(7), 603-616 (2007). (Pubitemid 47285406)
17. Sweetana S, Akers MJ, Solubility principles and practices for parenteral dosage form development, PDA. J. Pharm. Sci. Tech. 50(5), 330-342 (1996). (Pubitemid 26392756)
18. Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420(1), 1-10 (2011).
19. Datta S, Grant DJW. Crystal structures of drugs: advances in determination, prediction and engineering. Nat. Rev. Drug Discov. 3(1), 42-57 (2004). (Pubitemid 38088697)
20. Zhang GG, Law D, Schmitt EA, Qiu Y. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv. Drug Deliv. Rev. 56(3), 371-390 (2004). (Pubitemid 38202329)
21. Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17(4), 397-404 (2000). (Pubitemid 30395293)
22. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 48(1), 27-42 (2001). (Pubitemid 32454482)
23. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 12(23-24), 1068-1075 (2007). (Pubitemid 350186132)
24. Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21(10), 1762-1769 (2004). (Pubitemid 39390086)
25. Bhattacharya S, Suryanarayanan R. Local mobility in amorphous pharmaceuticalscharacterization and implications on stability. J. Pharm. Sci. 98(9), 2935-2953 (2009).
26. Chaumeil JC. Micronisation: a method of improving the bioavailability of poorly soluble drugs. Methods Find. Exp. Clin. Pharmacol. 20(3) 211-215 (1998). (Pubitemid 28255411)
27. Blagden, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv. Drug Deliv. Rev. 59(7), 617-630 (2007). (Pubitemid 47285407)
28. Shariare MH, de Matas M, York P, Shao Q. The impact of material attributes and process parameters on the micronisation of lactose monohydrate. Int. J. Pharm., 408(1-2), 58-66 (2011).
29. Xu R. Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology 6(7), 112-115 (2008). (Pubitemid 351512349)
30. Merisko-Liversidge E, Liversidge GL. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv. Drug Deliv. Rev. 63(6), 427-440 (2011).
31. Krishnaiah YSR. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J. Bioequiv. Bioavail. 2(2), 28-36 (2010).
32. Bottomley K, Nanotechnology for drug delivery: a validated technology? Drug Deliv. Rep. 20-21 (2006).
33. Verma S, Gokhale R, Burgess DJ. A comparative study of top-down and bottomup approaches for the preparation of micro/ nanosuspensions. Int. J. Pharm. 380(1-2), 216-222 (2009).
34. Patravale VB, Date AA, Kulkarni, RM. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 56(7), 827-840 (2004). (Pubitemid 38885975)
35. Strickley RG. Solubilising excipients in oral and injectable formulations. Pharm. Res. 21(2), 201-230 (2004). (Pubitemid 38221966)
36. Miyako Y, Khalef N, Matsuzaki K, Pinal R. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. Int. J. Pharm. 393(1-2), 48-54 (2010).
37. Rubino, JT. Cosolvents and cosolvency. In: Encyclopedia of Pharmaceutical Technology (2nd Edition). Swarbrick J, Boylan JC (Eds). Marcel Dekker Inc, NY, USA (1990).
38. Florence AT, Attwood D. Physicochemical Principles of Pharmacy (4th Edition). Pharmaceutical Press, London, UK (2011).
39. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev. Ind. Pharm. 29(9), 1013-1026. (2003). (Pubitemid 37346103)
40. Gregor C. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56(5), 675-711 (2004).
41. zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 45(2), 149-155 (1998). (Pubitemid 28167741)
42. Loftsson T, Brewster ME, Masson M, Role of cyclodextrins in improving oral drug delivery. Am. J. Drug Deliv. 2(4), 175-261 (2004).
43. Davis ME, Brewster ME, Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3(12), 1023-1035 (2004). (Pubitemid 39642365)
44. Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem. Pharm. Bull. 12, 134-144 (1964).
45. Vippagunta SR, Wang Z, Hornung S, Krill SL. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J. Pharm. Sci. 96(2), 294-304 (2006). (Pubitemid 46363560)
46. Shamblin SL, Zografi G. The effects of absorbed water on the properties of amorphous mixtures containing sucrose. Pharm. Res. 16(7), 1119-1124 (1999). (Pubitemid 29368163)
47. Alonzo DE, Zhang GGZ, Zhou D, Gao Y, Taylor LS. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm. Res. 27(4), 608-618 (2010).
48. Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin AT. Development of clinical dosage forms for a poorly water soluble drug I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J. Pharm. Sci. 93(5), 1165-1175 (2004). (Pubitemid 38529690)
49. Yoshioka S, Stella VJ. Stability of Drugs and Dosage Forms. Kluwer Academic/Plenum Publishers, New York, NY, USA (2002).
50. Reneker DH, Yarin AL, Zussman E, Xu H. Advances in Applied Mechanics. Aref H, Van Der Giessen (Eds). Elsevier/Academic Press, London, UK (2011).
51. Reneker, D. Yarin A. Electrospinning jets and polymer nanofibers. Polymer 49, 2387-2845 (2008).
52. Rutledge, G, Fridrikh S, Formation of fibers by electrospinning. Adv. Drug Deliv. Rev. 59(14), 1384-1391 (2007). (Pubitemid 350122769)
53. Cui W, Li X, Zhou S. Weng J. Investigation on process parameters of electrospinning system through orthogonal experiment design. J. Appl. Polym. Sci. 103(5), 3105-3112 (2007). (Pubitemid 46345598)
54. Zhang HL. Effects of electrospinning parameters on morphology and diameter of electrospun PLGA/MWNTs fibers and cytocompatibility in vitro. J. Bioact. Compat. Polym. 26(6), 590-606 (2011).
55. Jacobs V, Patanaik A, Anandjiwala RD, Maaza M. Optimization of electrospinning parameters for chitosan nanofibers. Curr. Nanosci. 6(6), 396-401 (2011).
56. Ho-Wang T, Min W. An investigation into the influence of electrospinning parameters on the diameter and alignment of poly(hydroxybutyrate-co- hydroxyvalerate) fibers. J. Appl. Polym. Sci. 120(3), 1694-1706 (2011).
57. Shin Y, Hohman M, Brenner M, Rutledge G. Experimental characterization of electrospinning: the electrically forced jet and instabilities. Polymer 42(9), 9955-9967 (2001). (Pubitemid 32899936)
58. Reneker D, Yarin A, Fong H, Koombhongse S, Bending instability of electrically charged liquid jets of polymer solutions in electrospinning. J. Appl. Phys. 87(9), 4531-4548 (2000).
59. Wang C, Cheng Y, Hsu, C, Chien H, Tsou S. How to manipulate the electrospinning jet with controlled properties to obtain uniform fibers with smallest diameter? A brief discussion of solution electrospinning process. J. Polymer Res. 18(1), 111-123 (2011).
60. Haghi A, Zaikov. G. Advances in Nanofiber Research. iSmithers, Akron, OH, USA, 31-34 (2011).
61. Wang T, Kumar S. Electrospinning of polyacrylonitrile nanofibers J. Appl. Polym. Sci. 102(43), 1023-1029 (2006). (Pubitemid 44518264)
62. Baker S, Atkin, N, Gunning N, Granville K, Wilson K, Wilson S, Southgate J. Characterisation of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies. Biomaterials 27(16), 3136-3146 (2006). (Pubitemid 43247587)
63. Dreitzel, J, Kleinmayer J, Harris D, Beck Tan N, The effect of processing variables on themorphology of electrospun nanofibers and textiles. Polymer 42, 261-272 (2001). (Pubitemid 33647356)
64. Li, D, Xia Y. Fabrication of titania nanofibers by electrospinning, Nano Lett. 3(4), 555-560 (2003). (Pubitemid 37140662)
65. Loscertales I, Barrero A, Guerrero I, Cortijo R, Marquez M, Ganan-Calvo A. Micro/nano encapsulation via electrified coaxial liquid jets. Science 295(5560), 1695-1698 (2002). (Pubitemid 34202901)
66. Li D, Xia Y, Direct fabrication of composite and ceramic hollow nanofibers by electrospinning. Nano Lett. 4(5), 933-938 (2004). (Pubitemid 38716353)
67. Chakraborty S, Liao IC, Adler A, Leong KW. Electrohydrodynamics: a facile technique to fabricate drug delivery systems. Adv. Drug Deliv. Rev. 61(12), 1043-1054 (2009).
68. Huang LY, Yu DG, Branford-White C, Zhu LM. Sustained release of ethyl cellulose micro-particulate drug delivery systems using electrospraying. J. Mater. Sci. 47, 1372-1377 (2012).
69. Yu DG, Zhang XF, Shen XX, Branford-White C, Zhu LM. Ultrafine ibuprofen-loaded polyvinylpyrrolidone fiber mats using electrospinning. Polym. Int. 58(9), 1010-1013 (2009).
70. Yu DG, Shen XX, Branford-White C, White K, Zhu LM, Bligh SWA. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology 20(5), 055104 (2009).
71. Yu DG, Branford-White C, Shen XX, Zhang XF, Zhu LM. Solid dispersions of ketoprofen in drug-loaded electrospin nanofibers. J. Dispers. Sci. Technol. 31(7), 902-908 (2010).
72. Kenawy ER, Abdel-Hay FI, El-Newehy ME, Wnek GE. Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater. Chem. Phys. 113(1), 296-302 (2009).
73. Meng ZX, Zheng W, Li L, Zheng YF. Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/ chitosan nanofibrous scaffold. Mater. Chem. Phys. 125, 505-611 (2011).
74. Yang DJ, Xiong C-D, Govender T, Wang YZ. Preparation and drug-delivery potential of metronidazole-loaded PELA tri-block copolymeric electrospun membranes. J. Biomater. Sci. Polym. 20(9), 1321-1334 (2009).
75. Yu DG, Yang JM, Branford-White C, Lu P, Zhang L, Zhu LM. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. Int. J. Pharm. 400, 158-164 (2010).
76. Han J, Chen TX, Branford-White CJ, Zhu LM. Electrospun shikonin-loaded PCL/ PTMC composite fiber mats with potential biomedical applications. Int. J. Pharm. 382(1-2), 215-221 (2009).
77. Peng JR, Qian ZY, Wang B et al. Preparation and release characteristics of quercetin loaded poly(lactic acid) ultrafine fibers. J. Nanosci. Nanotechnol. 11(4), 3659-3668 (2011).
78. Yu DG, Gao LD, White K, Branford-White C, Lu WY, Zhu LM. Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug. Pharm. Res. 27(11), 2466-2477 (2010).
79. Huang LY, Yu DG, Zhu LM, Branford-White CJ, White K. Preparation of fast-dissolving ursolic acid nanofiber membranes using electrospinning. Presented at: 5th International Conference on Bioinformatics and Biomedical Engineering. Wuhan, China, 10-12 May 2011.
80. Quan J, Yu Y, Branford-White C et al. Preparation of ultrafine fast-dissolving feruloyl-oleyl-glycerol-loaded polyvinylpyrrolidone fiber mats via electrospinning. Colloids Surf. 88(Suppl. B), 304-309 (2011).
81. Xu JQ, Jiao YP, Shao XH, Zhou CR. Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly (l-lactic acid) fiber mats loaded with chitosan microspheres. Mater. Lett. 65(17-18), 2800-2803 (2011).
82. Xu X, Chen X, Wang Z, Jing X. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur. J. Pharm. Biopharm. 72(1), 18-25 (2009).
83. Nagy ZK, Nyúl1 K, Wagner I, Molnár K, Marosi G. Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl. Express Polym. Lett. 4(12), 763-772 (2010).
84. Chen P, Wu QS, Ding YP, Chu M, Huang ZM, Hu W. A controlled release system of titanocene dichloride by electrospun fiber and its anti-tumor activity in vitro. Eur. J. Pharm. Biopharm. 76(3), 413-420 (2010).
85. Xu XL, Chen XS, Xu XY et al. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against glioma C6 cells. J. Control. Release 114(3), 307-316 (2006).
86. Park Y, Kang E, Kwon OJ et al. Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy. J. Control. Release 148(1), 75-82 (2010).
87. Shen XX, Yu DG, Zhu LM et al. Electrospun diclofenac sodium loaded Eudragit® L 100-155 nanofibers for colon-targeted drug delivery. Int. J. Pharm. 408(1-2), 200-207 (2011).
88. Park CG, Kim E, Park M, Park JH, Choy YB. A nanofibrous sheet-based system for linear delivery of nifedipine. J. Control. Release 149(3), 250-257 (2011).
89. Suganya S, Ram TS, Lakshmi BS, Giridev VR. Herbal drug incorporated antibacterial nanofibrous mat fabricated by electrospinning: an excellent matrix for wound dressings. J. Appl. Polym. Sci. 121(5), 2893-2899 (2011).
90. Kontogiannopoulosa KN, Assimopouloua AN, Tsivintzelis I, Panayiotoub C, Papageorgioua VP. Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. Int. J. Pharm. 409(1-2), 216-228 (2011).
91. Wu XM, Branford-White C, Yu D-G, Chatterton N, Zhu L-M, Preparation of Core-shell PAN nanofibers encapsulated a-tocopherol acetate and ascorbic acid 2-phosphate for photoprotection. Colloids Surf. B 82(1), 247-252 (2011).
92. Lu Y, Jiang H, Tu K, Wang L. Mild immobilization of diverse macromolecular bioactive agents onto multifunctional fibrous membranes prepared by coaxial electrospinning. Acta Biomater. 5(5), 1562-1574 (2009).
93. Roshkova R, Manolova N, Gardeva E et al. Antitumor activity of quaternized chitosanbased electrospun implants against Graffi myeloid tumor. Int. J. Pharm. 400, 221-233 (2010).
94. Huang HH, He CL, Wang SH, Mo XM. Preparation of core-shell biodegradable microfibers for long term drug delivery. J. Biomed. Mater. Res. 400(1-2), 1243-1251 (2009).
95. Xu X, Guo G, Fan Y. Fabrication and characterisation of dense zirconia and zirconia-ceramic nanofibers. J. Nanosci. Nanotechnol. 10(9), 5672-5679 (2010).
96. Yang F, Both SK, Yang X, Walboomers XF, Jansen JA. Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application. Acta Biomater. 5(9), 3295-3304 (2009).
97. Gao Y, Sagi S, Zhang LF et al. Electrospun nano-scaled glass fiber reinforcement of bis-GMA/TEGDMA dental composites. J. Appl. Polym. Sci. 48(9), 2063-2070 (2008).
98. Koepsell L, Remund T, Bao J, Neufeld D, Fong H, Deng Y. Tissue engineering of annulus fibrosus using electrospun fibrous scaffolds with aligned polycaprolactone fibers. J. Biomed. Mater. Res. 99(4), 564-575 (2011).
99. Lee CH, Lim YC, Farson DF, Powell HM, Lannutti JJ. Vascular wall engineering via femtosecond laser ablation: scaffolds with self containing smooth muscle cell populations. Annu. Biomed. Eng. 39(12), 3031-3041 (2011).
100. Sharma S, Mohanty S, Gupta D, Jassal M, Agrawal AK, Tandon R. Cellular response of limbal epithelial cells on electrospun poly-epsilon-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study. Mol. Vis. 17, 2898-2910 (2011).
101. Wu SC, Chang WH, Dong GC, Chen KY, Chen YS, Yao CH. Cell adhesion and proliferation enhancement by gelatin nanofiber scaffolds. J. Bioact. Compat. Polym. 27(1), 565-577 (2011).
102. Ma GP, Fang DW, Liu Y, Zhu XD, Nie J. Electrospun sodium alginate/poly(ethylene oxide) core-shell nanofibers scaffolds with potential for tissue engineering applications. Carbohydr. Polym. 87, 737-743 (2011).
103. Yu DG, Zhu LM, Branford-White C, Bligh SWA, White K. Coaxial electrospinning with organic solvent for controlling the size of self-assembled nanoparticles. Chem. Commun. 47(4), 1216-1218 (2011).
104. Yu DG, Branford-White C, Williams GR et al. Self-assembled liposomes from amphiphilic electrospun nanofibers. Soft Matter 7(18), 8239-8247 (2011).
105. Lichtenhalter FW, Immel S. Cyclodextrins, cyclomannins and cyclogalactins with five and six (1-4)-linked sugar units: a comparative assessment of their conformations and hydrophobicity potential profiles. Tetrahedron: Asymmetry, 5(11), 2045-2600 (1994).